These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 33991619)

  • 1. Pesticides and Parkinson's disease: Current and future perspective.
    Islam MS; Azim F; Saju H; Zargaran A; Shirzad M; Kamal M; Fatema K; Rehman S; Azad MAM; Ebrahimi-Barough S
    J Chem Neuroanat; 2021 Sep; 115():101966. PubMed ID: 33991619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alzheimer's Disease and Parkinson's Disease: A Nutritional Toxicology Perspective of the Impact of Oxidative Stress, Mitochondrial Dysfunction, Nutrigenomics and Environmental Chemicals.
    Agnihotri A; Aruoma OI
    J Am Coll Nutr; 2020 Jan; 39(1):16-27. PubMed ID: 31829802
    [No Abstract]   [Full Text] [Related]  

  • 3. Potential application of induced pluripotent stem cells in cell replacement therapy for Parkinson's disease.
    Chen LW; Kuang F; Wei LC; Ding YX; Yung KK; Chan YS
    CNS Neurol Disord Drug Targets; 2011 Jun; 10(4):449-58. PubMed ID: 21495962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic effects of Wharton's jelly-derived Mesenchymal Stromal Cells on behaviors, EEG changes and NGF-1 in rat model of the Parkinson's disease.
    Jalali MS; Saki G; Farbood Y; Azandeh SS; Mansouri E; Ghasemi Dehcheshmeh M; Sarkaki A
    J Chem Neuroanat; 2021 Apr; 113():101921. PubMed ID: 33600923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracarotid Infusion of Mesenchymal Stem Cells in an Animal Model of Parkinson's Disease, Focusing on Cell Distribution and Neuroprotective and Behavioral Effects.
    Cerri S; Greco R; Levandis G; Ghezzi C; Mangione AS; Fuzzati-Armentero MT; Bonizzi A; Avanzini MA; Maccario R; Blandini F
    Stem Cells Transl Med; 2015 Sep; 4(9):1073-85. PubMed ID: 26198165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapies for Parkinson's diseases: alternatives to current pharmacological interventions.
    Li S; Dong J; Cheng C; Le W
    J Neural Transm (Vienna); 2016 Nov; 123(11):1279-1299. PubMed ID: 27515029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An adverse outcome pathway for chemical-induced Parkinson's disease: Calcium is key.
    Meerman JJ; Legler J; Piersma AH; Westerink RHS; Heusinkveld HJ
    Neurotoxicology; 2023 Dec; 99():226-243. PubMed ID: 37926220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stem Cell Therapy for Parkinson's Disease.
    Han F; Hu B
    Adv Exp Med Biol; 2020; 1266():21-38. PubMed ID: 33105493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Environment, mitochondria, and Parkinson's disease.
    Sherer TB; Betarbet R; Greenamyre JT
    Neuroscientist; 2002 Jun; 8(3):192-7. PubMed ID: 12061498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The interplay between environmental and genetic factors in Parkinson's disease susceptibility: the evidence for pesticides.
    Dardiotis E; Xiromerisiou G; Hadjichristodoulou C; Tsatsakis AM; Wilks MF; Hadjigeorgiou GM
    Toxicology; 2013 May; 307():17-23. PubMed ID: 23295711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long term behavioral effects of functional dopaminergic neurons generated from human neural stem cells in the rat 6-OH-DA Parkinson's disease model. Effects of the forced expression of BCL-X(L).
    Ramos-Moreno T; Castillo CG; Martínez-Serrano A
    Behav Brain Res; 2012 Jun; 232(1):225-32. PubMed ID: 22537773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optogenetic Stimulation of the M2 Cortex Reverts Motor Dysfunction in a Mouse Model of Parkinson's Disease.
    Magno LAV; Tenza-Ferrer H; Collodetti M; Aguiar MFG; Rodrigues APC; da Silva RS; Silva JDP; Nicolau NF; Rosa DVF; Birbrair A; Miranda DM; Romano-Silva MA
    J Neurosci; 2019 Apr; 39(17):3234-3248. PubMed ID: 30782975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress in Dopaminergic Cell Replacement and Regenerative Strategies for Parkinson's Disease.
    Chen W; Huang Q; Ma S; Li M
    ACS Chem Neurosci; 2019 Feb; 10(2):839-851. PubMed ID: 30346716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pesticide and iPSC dopaminergic neuron screen identifies and classifies Parkinson-relevant pesticides.
    Paul KC; Krolewski RC; Lucumi Moreno E; Blank J; Holton KM; Ahfeldt T; Furlong M; Yu Y; Cockburn M; Thompson LK; Kreymerman A; Ricci-Blair EM; Li YJ; Patel HB; Lee RT; Bronstein J; Rubin LL; Khurana V; Ritz B
    Nat Commun; 2023 May; 14(1):2803. PubMed ID: 37193692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Replacing what's lost: a new era of stem cell therapy for Parkinson's disease.
    Fan Y; Winanto ; Ng SY
    Transl Neurodegener; 2020; 9():2. PubMed ID: 31911835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Update on Human Stem Cell-Based Therapy in Parkinson's Disease.
    González C; Bonilla S; Flores AI; Cano E; Liste I
    Curr Stem Cell Res Ther; 2016; 11(7):561-8. PubMed ID: 26027681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human autologous iPSC-derived dopaminergic progenitors restore motor function in Parkinson's disease models.
    Song B; Cha Y; Ko S; Jeon J; Lee N; Seo H; Park KJ; Lee IH; Lopes C; Feitosa M; Luna MJ; Jung JH; Kim J; Hwang D; Cohen BM; Teicher MH; Leblanc P; Carter BS; Kordower JH; Bolshakov VY; Kong SW; Schweitzer JS; Kim KS
    J Clin Invest; 2020 Feb; 130(2):904-920. PubMed ID: 31714896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dietary restriction and 2-deoxyglucose administration improve behavioral outcome and reduce degeneration of dopaminergic neurons in models of Parkinson's disease.
    Duan W; Mattson MP
    J Neurosci Res; 1999 Jul; 57(2):195-206. PubMed ID: 10398297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
    Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
    Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
    During MJ; Kaplitt MG; Stern MB; Eidelberg D
    Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.